COVID-19感染后至手术时间与术后心血管并发症风险的关联
该单中心回顾性队列纳入2020年1月1日至2021年12月6日接受手术、且有PCR阳性确诊COVID-19史的3997例成人患者,分析COVID-19诊断至手术的时间间隔与术后30天主要心血管不良事件复合终点(深静脉血栓、肺栓塞、脑血管意外、心肌损伤、急性肾损伤和死亡)的关联。结果显示485例(12.1%)发生复合终点事件;诊断至手术时间每延长10天,复合终点调整OR为0.99(95%CI 0.98-1.00,P=0.006);在至少接种1剂COVID-19疫苗的1552例中,该趋势持续(调整OR 0.98/10天,95%CI 0.97-1.00,P=0.04)。作者认为该信息可用于有COVID-19感染史患者最佳手术时机与围手术期结局的风险-获益讨论。
要点
- 有COVID-19确诊史并接受手术的成人中,术后30天主要心血管不良事件复合终点发生率为12.1%(485/3997)。
- COVID-19诊断至手术时间每延长10天,复合终点调整OR为0.99(95%CI 0.98-1.00,P=0.006)。
- 至少接种1剂COVID-19疫苗的1552例中,每延长10天调整OR为0.98(95%CI 0.97-1.00,P=0.04)。
- 复合终点包括深静脉血栓、肺栓塞、脑血管意外、心肌损伤、急性肾损伤和死亡。
- 作者认为该信息可用于有COVID-19感染史患者手术时机与围手术期结局的风险-获益讨论。
适用人群与场景
- 单中心成人患者(年龄≥18岁),有PCR阳性确诊的COVID-19病史,于2020年1月1日至2021年12月6日接受手术。
研究设计与关键结果
- 研究类型:单中心、回顾性队列研究,样本量3997例;女性2223例(55.6%),中位年龄51.3岁(IQR 35.1-64.4岁),非裔美国人或黑人667例(16.7%),白人2990例(74.8%),其他种族340例(8.5%)。
- COVID-19诊断至手术的中位时间为98天(IQR 30-225天)。
- 主要终点:术后30天主要心血管不良事件复合终点(深静脉血栓、肺栓塞、脑血管意外、心肌损伤、急性肾损伤和死亡)发生于485例(12.1%)。
- 诊断至手术时间每延长10天,复合终点调整OR为0.99(95%CI 0.98-1.00,P=0.006)。
- 至少接种1剂COVID-19疫苗的1552例中,每延长10天调整OR为0.98(95%CI 0.97-1.00,P=0.04)。
证据类型、等级与局限
- 证据类型:单中心、回顾性队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,延长COVID-19诊断至手术的时间与术后主要心血管不良事件复合终点odds降低相关,该信息可用于有COVID-19感染史患者最佳手术时机与围手术期结局的风险-获益讨论。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
IMPORTANCE: The time interval between COVID-19 infection and surgery is a potentially modifiable but understudied risk factor for postoperative complications.
OBJECTIVE: To examine the association between time to surgery after COVID-19 diagnosis and the risk of a composite of major postoperative cardiovascular morbidity events within 30 days of surgery.
DESIGN, SETTING, AND PARTICIPANTS: This single-center, retrospective cohort study was conducted among 3997 adult patients (aged ≥18 years) with a previous diagnosis of COVID-19, as documented by a positive polymerase chain reaction test result, who were undergoing surgery from January 1, 2020, to December 6, 2021. Data were obtained through Structured Query Language access of an existing perioperative data warehouse. Statistical analysis was performed March 29, 2022.
EXPOSURE: The time interval between COVID-19 diagnosis and surgery.
MAIN OUTCOMES AND MEASURES: The primary outcome was the composite occurrence of major cardiovascular comorbidity, defined as deep vein thrombosis, pulmonary embolism, cerebrovascular accident, myocardial injury, acute kidney injury, and death within 30 days after surgery, using multivariable logistic regression.
RESULTS: A total of 3997 patients (2223 [55.6%]; median age, 51.3 years [IQR, 35.1-64.4 years]; 667 [16.7%] African American or Black; 2990 [74.8%] White; and 340 [8.5%] other race) were included in the study. The median time from COVID-19 diagnosis to surgery was 98 days (IQR, 30-225 days). Major postoperative adverse cardiovascular events were identified in 485 patients (12.1%). Increased time from COVID-19 diagnosis to surgery was associated with a decreased rate of the composite outcome (adjusted odds ratio, 0.99 [per 10 days]; 95% CI, 0.98-1.00; P = .006). This trend persisted for the 1552 patients who had received at least 1 dose of COVID-19 vaccine (adjusted odds ratio, 0.98 [per 10 days]; 95% CI, 0.97-1.00; P = .04).
CONCLUSIONS AND RELEVANCE: This study suggests that increased time from COVID-19 diagnosis to surgery was associated with a decreased odds of experiencing major postoperative cardiovascular morbidity. This information should be used to better inform risk-benefit discussions concerning optimal surgical timing and perioperative outcomes for patients with a history of COVID-19 infection.
参考来源
- Bryant JM, Boncyk CS, Rengel KF, et al. Association of Time to Surgery After COVID-19 Infection With Risk of Postoperative Cardiovascular Morbidity. JAMA Netw Open. 2022. PMID: 36515945. doi:10.1001/jamanetworkopen.2022.46922
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。